These Analysts Boost Their Forecasts On IQVIA After Better-Than-Expected Earnings

IQVIA Holdings Inc IQV posted better-than-expected second-quarter earnings on Monday.

IQVIA reported a second adjusted EPS of $2.64, up from $2.43, beating the consensus of $2.57. Provider of advanced analytics reported sales of $3.81 billion, beating the consensus of $3.79 billion, according to data from Benzinga Pro.

Technology & Analytics Solutions (TAS) revenue of $1.5 billion increased 2.7% on a reported basis and 3.8% at constant currency. Research & Development Solutions (R&DS) revenue reached $2.15 billion, increasing 2.4% on a reported basis and 3.3% at constant currency.

"IQVIA delivered second-quarter results at the high-end of our guidance, driven mainly by better-than-expected TAS performance," stated Ari Bousbib, chairman and CEO of IQVIA.

IQVIA said it expects 2024 revenues of $15.43 billion—$15.53 billion, compared to prior guidance of $15.33 billion—$15.58 billion and a consensus of $15.46 billion. IQVIA expects 2024 adjusted EPS of $11.10-$11.30 compared to prior guidance of $10.95-$11.25 and consensus of $11.08.

IQVIA shares closed at $245.23 on Monday.

These analysts made changes to their price targets on IQVIA following the announcement.

  • Baird analyst Eric Coldwell maintained IQVIA with a Neutral rating and raised the price target from $235 to $251.
  • Barclays analyst Luke Sergott maintained the stock with an Overweight rating and increased the price target from $255 to $275.
  • Evercore ISI Group analyst Elizabeth Anderson maintained IQVIA with an Outperform and raised the price target from $230 to $270.

Read More:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPrice TargetMarketsAnalyst RatingsTrading IdeasPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!